6-FAM SE
CAS No. 92557-81-8
6-FAM SE( 6-Carboxyfluorescein N-succinimidyl ester )
Catalog No. M27030 CAS No. 92557-81-8
6-FAM SE is another isomer of carboxyfluorescein. 6-FAM SE is mainly used for labeling nucleotides and sequencing nucleic acids.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 25MG | 74 | In Stock |
|
| 50MG | 133 | In Stock |
|
| 100MG | 221 | In Stock |
|
| 200MG | 328 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-FAM SE
-
NoteResearch use only, not for human use.
-
Brief Description6-FAM SE is another isomer of carboxyfluorescein. 6-FAM SE is mainly used for labeling nucleotides and sequencing nucleic acids.
-
Description6-FAM SE is another isomer of carboxyfluorescein. 6-FAM SE is mainly used for labeling nucleotides and sequencing nucleic acids.
-
In Vitro——
-
In Vivo——
-
Synonyms6-Carboxyfluorescein N-succinimidyl ester
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number92557-81-8
-
Formula Weight473.393
-
Molecular FormulaC25H15NO9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (105.62 mM)
-
SMILESOc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccc(cc23)C(=O)ON2C(=O)CCC2=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Oxeladin citrate
Oxeladin is a cough suppressant. It is a highly potent and effective drug used to treat all types of cough of various etiologies.
-
VIR-165
VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
Cart
sales@molnova.com